(Times of Israel) Shoshanna Solomon - Medial EarlySign, an Israeli startup, has developed machine learning-based software that analyzes standard blood test results to identify patients at high risk of colon cancer. Medial EarlySign taps into the databases of healthcare organizations to analyze the blood patterns of patients afflicted with colon cancer. The company is working on finding blood patterns for other illnesses including flu, diabetes and hypertension.
2018-08-30 00:00:00Full ArticleBACK Visit the Daily Alert Archive